SuperSeed
Early-stage investor backing technical founders applying AI to the physical world
- Venture capital
- London
- Type
- Venture capital
- Based in
- London
- Stages
- Pre-seed, Seed
- Sector focus
- AI & Data, SaaS & B2B
- Cheque size
- €100k–€1.5M
- Fund size
- Undisclosed
- Website
- superseed.com
SuperSeed is an early-stage venture capital firm that invests in technical founders using artificial intelligence in physical-world industries such as manufacturing, autonomous systems and supply chains. Most of its team have built and sold their own start-ups, and the firm supports portfolio companies with go-to-market planning, in-house talent hiring and introductions to customers and later investors.
Its portfolio includes Ai Build, Octaipipe, Garvis and Techsembly. SuperSeed Ventures LLP, which is authorised by the Financial Conduct Authority, is the principal manager for SuperSeed Capital, a Guernsey-domiciled fund quoted on the Aquis Growth Market since January 2022 that gives public investors exposure to a portfolio of start-ups.
Team
- Mads Jensen, Managing Partner LinkedIn
- Dan Bowyer, Partner LinkedIn
- Andrew Sherlock, Managing Director LinkedIn
Portfolio in the directory
← All investors · Is this your organisation? Request an update
More investors in the directory
ICONIQ Growth
San Francisco growth investor affiliated with ICONIQ Capital; co-led ElevenLabs' Series C and Motorway's Series C
General Atlantic
New York growth equity firm with USD 130bn AUM; led Flo Health's Series C and Fresha's Series C
Fidelity International
Global asset manager that also takes late-stage private stakes; invested in Gousto and Kraken Technologies
Faber
Lisbon deep tech seed fund (first tickets up to EUR 2.5m); led Biographica and co-led Ponda seed rounds
CPP Investments
Canada's national pension fund manager; growth investor in Octopus Energy and 9fin
CPI
UK deep tech innovation centre whose CPI Enterprises arm backs pre-seed and seed start-ups; backed Qualus and DEScycle
Subscribe to Newsletter
UK startup news, founder stories and funding insight, straight to your inbox every week. Free.